medigraphic.com
ISSN 1817-5996 (Electronic)

2021, Number 3

<< Back Next >>

Rev Cub de Reu 2021; 23 (3)

Considerations for benign joint hypermobility syndrome

Figueroa RDV, Cruz CJS, Romero ZEC, Kalil SKT

Language: Spanish
References: 25
Page:
PDF size: 461.68 Kb.


ABSTRACT

Benign joint hypermobility syndrome is the appearance of musculoskeletal symptoms in hypermobile individuals in the absence of systemic rheumatologically disease. To show the results of a bibliographic review on joint hypermobility and its clinical manifestations. Hypermobility can occur in several different connective tissue disorders, including Marfan syndrome, Ehlers-Danlos syndrome, and osteogenesis imperfect. It can also be found in certain chromosomal, genetic, and metabolic disorders. Identifying joint hypermobility on a regular basis, and JHS is not a difficult task, as long as it is part of clinical thinking, which would help to avoid its complications and diagnostic delays, which would solve a not inconsiderable measure of cases that they are regularly cared for in daily medical practice.


REFERENCES

  1. Hakim AJ, Cherkas LF, Grahame R, Spector TD, MacGregor AJ. The genetic epidemiology of joint hypermobility: a population study of female twins. Arthritis Rheum. 2004 [Acceso 12/08/2021];50(8):2640-4. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.20376

  2. Bulbena A, Duró JC, Porta M, Faus S, Vallescar R, Martin-Santos R. Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol. 1992 [Acceso 12/08/2021];19(1):115-22. Disponible en: Disponible en: https://europepmc.org/article/med/1556672

  3. Martínez JP, Suarez R, Menéndez F. El síndrome de hiperlaxitud articular en la práctica clínica diaria. Rev Cubana Reumatol. 2013 [Acceso 12/08/2021];15(1):36-40. Disponible en: Disponible en: https://europepmc.org/article/med/1556672

  4. Seckin Ü, Sonel Tur B, Yilmaz Ö, Yağci I, Bodur H, Arasil T. The prevalence of joint hypermobility among high school students. Rheumatol Int. 2005 [Acceso 12/08/2021];25:260-3. Disponible en: Disponible en: https://link.springer.com/article/10.1007%2Fs00296-003-0434-9

  5. Engelbert R, Uiterwaal C, Van de Putte E, Helders P, Sakkers R, Van Tintelen P, et al. Pediatric generalized joint hypomobility and musculoskeletal complaints: a new entity? Clinical, biochemical, and osseal characteristics. Pediatrics. 2004 [Acceso 12/08/2021];113(4):714-9. Disponible en: Disponible en: http://pediatrics.aappublications.org/cgi/content/full/113/4/714

  6. Everman DB, Robin NH. Hypermobility syndrome. Pediatr Rev. 1998 [Acceso 12/08/2021];19(4):111-7. Disponible en: Disponible en: https://pedsinreview.aappublications.org/content/19/4/111

  7. Larsson LG, Baum J, Mudholkar GS, Kollia GD. Benefits and disadvantages of joint hypermobility among musicians. N Engl J Med. 1993 [Acceso 12/08/2021];329(15):1079-82. Disponible en Disponible en http://content.nejm.org/cgi/content/full/329/15/1079

  8. de Inocencio J, Ocaña I, Benito L. Laxitud articular: prevalencia y relación con dolor musculosquelético. Joint hypermobility: prevalence and relationship with musculoskeletal pain. An Pediatr (Barc). 2004 [Acceso 12/08/2021];61(2):162-6. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1695403304783757

  9. Gedalia A, Brewer EJ. Joint hypermobility in pediatric practice-a review. J Rheumatol. 1993 [Acceso 12/08/2021];20(2):371-4. Disponible en: Disponible en: https://europepmc.org/article/med/8474078

  10. Magnusson SP, Julsgaard C, Aagaard P, Zacharie C, Ullman S, Kobayasi T, et al. Viscoelastic properties and flexibility of the human muscle-tendon unit in benign joint hypermobility syndrome. J Rheumatol. 2001 [Acceso 12/08/2021];28(12):2720-5. Disponible en: Disponible en: https://europepmc.org/article/med/11764223

  11. Gumá M, Olivé A, Holgado S, Forcada J, Duró JC, Tena X, et al. Una estimación de la laxitud articular en la consulta externa. Rev Esp Reumatol. 2001 [Acceso 12/08/2021];28(7):298-300. Disponible en: Disponible en: https://medes.com/publication/1049amp/Help.aspx?src=privacypolicy

  12. Russek LN. Examination and treatment of a patient with hypermobility syndrome. Phys Ther. 2000 [Acceso 12/08/2021];80(4):386-98. Disponible en: Disponible en: http://www.ptjournal.org/cgi/content/full/80/4/386

  13. Grahame R, Edwards JC, Pitcher D, Gabell A, Harvey W. A clinical and echocardiographic study of patients with the hypermobility syndrome. Ann Rheum Dis. 1981 [Acceso 12/08/2021];40(6):541-6. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1000826/

  14. Mishra MB, Ryan P, Atkinson P, Taylor H, Bell J, Calver D, et al. Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol. 1996 [Acceso 12/08/2021];35(9):861-6. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/8810669/

  15. Bravo JF. Síndrome de Ehlers-Danlos con especial énfasis en el síndrome de hiperlaxitud articular. Rev Méd Chile. 2009 [Acceso 12/08/2021];137(11):1488-97. Disponible en: Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-537014

  16. Mulvey MR, Macfarlane GJ, Beasley M, Symmons DP, Lovell K, Keeley P, et al. Modest association of joint hypermobility with disabling and limiting musculoskeletal pain: results from a large-scale general population-based survey. Arthritis Care Res (Hoboken). 2013 [Acceso 12/08/2021];65(8):1325-33. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/acr.21979

  17. Adib N, Davies K, Grahame R, Woo P, Murray KJ. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology (Oxford). 2005 [Acceso 12/08/2021];44(6):744-50. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/15728418/

  18. Hermanns-Lê T, Piérard GE. Ultrastructural alterations of elastic fibers and other dermal components in Ehlers-Danlos syndrome of the hypermobile type. Am J Dermatopathol. 2007 [Acceso 12/08/2021];29(4):370-3. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/17667170/

  19. Bicca EBC, Almeida FB, Pinto GM, Castro LAS, Almeida Jr. HLA Classical Ehlers-Danlos syndrome: clinical, Histological and ultrastructural aspects. An Bras Dermatol. 2011 [Acceso 12/08/2021];86(4Supl1):S164-7. Disponible en: Disponible en: https://www.scielo.br/j/abd/a/RL6VNN7JytsKxC43m9mH3ZQ/?format=pdf&lang=en

  20. Skoumal M, Haberhauer G, Mayr H. Begleiterkrankungen bei primärer gelenkhypermobilität. Med Klin. 2004 [Acceso 12/08/2021];99:585-90. Disponible en: Disponible en: https://link.springer.com/article/10.1007/s00063-004-1086-6

  21. Castori M, Sperduti I, Celletti C, Camerota F, Grammatico P. Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type). Clin Exp Rheumatol. 2011 [Acceso 12/08/2021];29(6):998-1005. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/22208933/

  22. MedlinePlus Información de salud para usted. Síndrome de Marfán. 2021 [Acceso 20/08/2021]. Disponible en Disponible en https://medlineplus.gov/spanish/ency/article/000418.htm

  23. Geroy E, Quiñones M, Acosta A. Síndrome de Marfán: a propósito de dos casos. Rev Finlay. 2020 [Acceso 12/08/2021];10(1):[aprox. 10 p.]. Disponible en: Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/793

  24. Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J Rheumatology. 2011 [Acceso 12/08/2021];38(5):828-34. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/21362765/

  25. McCormack M, Briggs J, Hakim A, Grahame R. Joint laxity and the benign joint hypermobility syndrome in student and professional ballet dancers. J Rheumatol. 2004 [Acceso 12/08/2021];31(1):173-8. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/14705238/




2020     |     www.medigraphic.com